Aurora Biosciences
This article was originally published in Start Up
Executive Summary
Drug Discovery Tools; Aurora is developing functional screening systems that indicate how a compound affects a particular target, that is, whether it inhibits or activates a molecular event. Aurora’s cell-based screens, based on living mammalian cells, provide optical readouts on biochemical processes in real time. Cells engineered to express a particular target respond with fluorescence changes when a compound "hits" the target. Update: Aurora Biosciences went public, netting $37.2 million in its J